Looking for COVID treatment in New Braunfels? We offer Remdesivir infusions; the only FDA-approved therapy for outpatient treatment of COVID. We also offer PCR COVID testing, with results in 30 minutes.

Remdesivir Treatment

January 21, 2022 – Received FDA Approval for treatment of outpatients with Covid and clinical risks for progression to severe disease.

Remdesivir (Veklury) is designed for treating RNA-based viruses that maintain global pandemic potential (Ebola, SARS, MERS).

Remdesivir is the only FDA-approved treatment (taken 3 consecutive days via IV) that reduces hospitalization by 87%.

How does it work?

An infusion that lasts 30-120 minutes on day 1, 2, and 3. Labs are checked daily before administration and observed 1 hour following infusion.

Key Inclusion Criteria:

Either:

  • Age ≥ 18 years with at least 1 pre-existing risk factor for progression to hospitalization
  • chronic lung disease
  • hypertension
  • cardiovascular or cerebrovascular disease
  • diabetes
  • obesity (body mass index ≥ 30)
  • immunocompromised
  • chronic mild or moderate kidney disease
  • chronic liver disease
  • current cancer
  • sickle cell disease
  • Or aged ≥ 60 years
  • Positive test for COVID
  • ≥ 1 symptom(s) of COVID-19 for ≤ 7 days


Not currently requiring hospitalization